Announced Sat, 11 Jul · 14:48 IST
Board approves Rs 15.48 cr SIGPL acquisition and Rs 210 cr rights issue
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Price reaction · full curve 14 horizons · vs prior close
+10.2%1-day move
₹85.62
prior close
—
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
————+10.2+15.7+21.5+27.6+34.0+47.7————
Up moveDown movePending
AI summary
Arvaya Healthcare (formerly Bijoy Hans) board approved acquiring 100% of Sushodha Institute of Gastroenterology (SIGPL) for Rs 15.48 cr via share swap, issuing 38.71 lakh shares at Rs 40 each (Rs 30 premium). Also approved a rights issue up to Rs 210 crores. Registered office shifted from Assam to Maharashtra. Acquisition subject to shareholder and regulatory approval.
Likely market impact
Share-swap acquisition will dilute equity but add a healthcare revenue stream. Rights issue may raise fresh capital from existing shareholders.